分子乳腺成像词典病变描述词的恶性阳性预测值
本回顾性研究纳入2005年8月1日至2017年8月31日间按临床报告为阳性(BI-RADS类似分类0、3、4、5或6)且有可用参考标准的分子乳腺成像检查,评估MBI词典中影像描述词对恶性的阳性预测值。共分析509例患者643个病变,结果显示肿块、多体位可见及摄取强度明显的病变阳性预测值较高,非肿块摄取中段性分布者阳性预测值最高。
要点
- 肿块阳性预测值为73.5%(61/83),非肿块摄取为18.4%(103/560)。
- 非肿块摄取中,段性分布阳性预测值最高(36.2%,17/47)。
- 四个体位均可见的病变阳性预测值为45.4%(113/249)。
核心结论
- MBI词典病变描述词与恶性可能性相关,肿块、多体位可见及摄取强度明显的病变阳性预测值较高,非肿块摄取中段性分布者阳性预测值最高。
研究设计与样本
- 回顾性研究,纳入2005年8月1日至2017年8月31日间阳性且有参考标准的MBI检查,使用双探测器碲锌镉MBI系统,注射99mTc sestamibi后成像,共509例患者643个病变(479良性,164恶性;83个肿块,560个非肿块摄取),由两名放射科医师之一按已发表MBI词典评估。
关键影像表现/征象
- 病变按MBI词典分为肿块与非肿块摄取,非肿块摄取进一步按分布描述。
- 肿块阳性预测值73.5%(61/83),非肿块摄取阳性预测值18.4%(103/560)。
- 非肿块摄取中,段性分布阳性预测值36.2%(17/47),局灶性20.1%(77/384),弥漫性30.8%(4/13),区域或多区域分布4.3%(5/116)。
- 病变见于一个体位时阳性预测值5.3%(5/94),两个体位15.2%(32/210),三个体位14.6%(13/89),四个体位45.4%(113/249)。
- 摄取强度轻度阳性预测值14.0%(43/307),中度22.4%(51/228),明显64.8%(70/108)。
诊断标准与关键数值
- 分类3病变以病理对照、至少2年影像随访或随访最终消退为分类1或2作为参考标准;分类4和5病变以病理对照为参考标准。
- 阳性检查定义为BI-RADS类似分类0、3、4、5或6。
临床应用与阅片要点
- 了解MBI词典描述词相关的恶性可能性可辅助放射科医师解读,并可能指导未来将MBI词典纳入ACR BI-RADS图谱。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. Molecular breast imaging (MBI) is used for various breast imaging indications. An MBI lexicon has been developed, although the likelihood of malignancy of the lexicon descriptors has not been assessed to our knowledge. OBJECTIVE. The purpose of this article was to evaluate the PPV for malignancy of the MBI lexicon imaging descriptors. METHODS. This retrospective study included MBI examinations performed from August 1, 2005, through August 31, 2017, that were positive (BI-RADS analogous categories 0, 3, 4, 5, or 6) according to the clinical report and had an available reference standard. Examinations were performed using dual-detector cadmium zinc telluride MBI systems after injection of 99mTc sestamibi. Category 3 lesions had pathologic correlation, at least 2 years of imaging follow-up, or final resolution on follow-up imaging as category 1 or 2; category 4 and 5 lesions had pathologic correlation. MBI examinations were reviewed by one of two radiologists to assess lesions on the basis of the published MBI lexicon for type (mass vs nonmass uptake), distribution (if nonmass uptake), uptake intensity, and number of MBI views on which the lesion was seen. PPV for malignancy was summarized. RESULTS. The analysis included 643 lesions (479 benign, 164 malignant; 83 mass, 560 nonmass uptake) in 509 patients (median age, 56 years). PPV was 73.5% (61/83) for masses and 18.4% (103/560) for nonmass uptake. Among the nonmass uptake lesions, PPV was 36.2% (17/47) for segmental, 20.1% (77/384) for focal, 30.8% (4/13) for diffuse, and 4.3% (5/116) for regional or multiple regional distribution. PPV was 5.3% (5/94) for one view, 15.2% (32/210) for two views, 14.6% (13/89) for three views, and 45.4% (113/249) for four views showing the lesion. PPV was 14.0% (43/307) for mild, 22.4% (51/228) for moderate, and 64.8% (70/108) for marked uptake intensity. CONCLUSION. The MBI lexicon lesion descriptors are associated with likelihood of malignancy. PPV was higher for masses, lesions seen on multiple MBI views, and lesions with marked uptake intensity. Among nonmass uptake lesions, PPV was highest for those with segmental distribution. CLINICAL IMPACT. Insight into the likelihood of malignancy associated with the MBI lexicon descriptors can inform radiologists' interpretations and guide potential future incorporation of the MBI lexicon into the ACR BI-RADS Atlas.
引用
- Hunt, Conners, Samreen, et al. PPV of the Molecular Breast Imaging Lexicon. AJR Am J Roentgenol. 2022. PMID: 35856455. doi:10.2214/AJR.21.27047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。